高分子創薬アウトソーシング市場、規模、シェア、産業分析レポート：サービス別、ワークフロー別、治療分野別、最終用途別、地域別、2025年～2034年の市場予測

Polaris Market Research社の最新調査によると、高分子創薬アウトソーシング市場規模は2034年までに65億3,000万米ドルに達する見込みです。同レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

高分子創薬アウトソーシングとは、標的の検証、HITの同定、候補化合物の最適化など、生物学的研究の初期段階の活動を専門の外部パートナーに委託し、効率性と革新性を向上させることを指します。生物学的製剤や新規治療法への注目が高まっており、自社ではなかなか得られない専門的な能力が求められていることが、成長機会をさらに後押ししています。バイオ医薬品企業が、モノクローナル抗体、融合タンパク質、核酸ベースの医薬品など、複雑な高分子の研究開発を加速させようとしているため、適切な技術的・科学的専門知識を持つ開発業務受託機関（CRO）へのアウトソーシングが戦略的に必要となっています。このアプローチは、高い科学的水準を維持しながら、リソースの利用を最適化し、初期段階の探索スケジュールを短縮します。

AI主導の創薬、バイオインフォマティクス、ハイスループットスクリーニングプラットフォームなどの先端技術のアウトソーシングモデルへの統合が進んでいることが、高分子創薬アウトソーシング市場の需要を形成しています。これらのツールは、データ分析、予測モデリング、分子設計を改善し、CROがより精密で効率的な創薬プロセスを提供することを後押ししています。生物学的製剤の領域で競合が激化する中、企業はより迅速なターンアラウンド、生物学的メカニズムへの深い洞察、実現可能な新薬候補を特定する高い可能性を提供するテクノロジー対応のパートナーをますます優先するようになっています。このような技術主導のアウトソーシング・パートナーシップへのシフトは、高分子創薬全体のイノベーションのペースと質を再定義すると予想されます。

高分子創薬アウトソーシング市場レポートハイライト

ワークフロー別では、リード化合物の同定および候補化合物の最適化分野が2024年に最大の市場シェアを占めました。これは、生物製剤開発において最適な治療効果、安全性、薬物様特性を確保するためにリード化合物を精製する上で重要な役割を果たすためです。

サービス別に見ると、化学サービス分野は、高分子医薬品候補化合物の構造的完全性、安定性、機能性を向上させる重要性に後押しされ、顕著な拡大が見込まれています。

2024年、北米は成熟したバイオ医薬品産業、強力な調査投資、生物製剤に特化した研究機関の強固なネットワークに支えられ、最大の売上シェアを占めました。

アジア太平洋地域の高分子創薬アウトソーシング市場は、アウトソーシング需要の高まり、コスト面での優位性、生物製剤研究に特化したインフラ整備の進展などを背景に、予測期間中に急成長が見込まれます。

世界の主な市場開拓企業には、Charles River Laboratories、Dalton Pharma Services、Domainex、Eurofins Discovery、Evotec SE、GenScript、Jubilant Biosys Limited、Labcorp.（Covance）、Merck &Co. Inc.、Pharmaceutical Product Development, LLC（PPD、Thermo Fisher傘下）、Pharmaron、QIAGEN、Syngene International Limited、TCG Lifesciences Pvt Ltd.、WuXi AppTecなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の高分子創薬アウトソーシング市場の洞察

• 市場スナップショット
• 高分子創薬アウトソーシング市場力学
  • 促進要因と機会
    • パートナーシップとプラットフォームベースのコラボレーションの増加
    • 創薬技術の進歩
  • 抑制要因と課題
    • 関税によるサプライチェーンの混乱とコスト増加
• PESTEL分析
• 高分子創薬アウトソーシング市場動向
• バリューチェーン分析

第5章 世界の高分子創薬アウトソーシング市場：ワークフロー別

• 主な調査結果
• イントロダクション
• ターゲットの特定とスクリーニング
• ターゲット検証と機能情報科学
• リード特定と候補者最適化
• 前臨床開発
• その他

第6章 世界の高分子創薬アウトソーシング市場：サービス別

• 主な調査結果
• イントロダクション
• 化学サービス
• 生物学サービス

第7章 世界の高分子創薬アウトソーシング市場：治療分野別

• 主な調査結果
• イントロダクション
• 呼吸器系
• 痛みと麻酔
• 腫瘍学
• 眼科
• 血液学
• その他

第8章 世界の高分子創薬アウトソーシング市場：最終用途別

• 主な調査結果
• イントロダクション
• 医薬品・バイオテクノロジー
• 学術機関

第9章 世界の高分子創薬アウトソーシング市場：地域別

• 主な調査結果
• イントロダクション
  • 高分子創薬アウトソーシング市場分析：地域別、2020～2034年
• 北米
  • 北米：ワークフロー別、2020～2034年
  • 北米：サービス別、2020～2034年
  • 北米：治療分野別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：ワークフロー別、2020～2034年
  • 欧州：サービス別、2020～2034年
  • 欧州：治療分野別、2020～2034年
  • 欧州：最終用途別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋地域
  • アジア太平洋地域：ワークフロー別、2020～2034年
  • アジア太平洋地域：サービス別、2020～2034年
  • アジア太平洋地域：治療分野別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：ワークフロー別、2020～2034年
  • 中東・アフリカ：サービス別、2020～2034年
  • 中東・アフリカ：治療分野別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：ワークフロー別、2020～2034年
  • ラテンアメリカ：サービス別、2020～2034年
  • ラテンアメリカ：治療分野別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Charles River Laboratories
• Dalton Pharma Services
• Domainex
• Eurofins Discovery
• Evotec SE
• GenScript
• Jubilant Biosys Limited
• Labcorp.（Covance）
• Labcorp.（Covance）
• Pharmaceutical Product Development, LLC（PPD, part of Thermo Fisher）
• Pharmaron
• QIAGEN
• Syngene International Limited
• TCG Lifesciences Pvt Ltd.
• WuXi AppTec

List of Tables:

• Table 1 Global Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 2 Global Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 3 Global Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 4 Global Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 5 North America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 6 North America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 7 North America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 8 North America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 9 US: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 10 US: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 11 US: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 12 US: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 13 Canada: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 14 Canada: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 15 Canada: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 16 Canada: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 17 Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 18 Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 19 Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 20 Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 21 UK: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 22 UK: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 23 UK: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 24 UK: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 25 France: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 26 France: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 27 France: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 28 France: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 29 Germany: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 30 Germany: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 31 Germany: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 32 Germany: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 33 Italy: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 34 Italy: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 35 Italy: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 36 Italy: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 37 Spain: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 38 Spain: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 39 Spain: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 40 Spain: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 41 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 42 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 43 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 44 Netherlands: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 45 Russia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 46 Russia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 47 Russia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 48 Russia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 57 China: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 58 China: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 59 China: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 60 China: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 61 India: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 62 India: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 63 India: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 64 India: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 65 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 66 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 67 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 68 Malaysia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 69 Japan: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 70 Japan: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 71 Japan: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 72 Japan: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 73 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 74 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 75 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 76 Indonesia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 77 South Korea: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 78 South Korea: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 79 South Korea: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 80 South Korea: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 81 Australia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 82 Australia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 83 Australia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 84 Australia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 97 UAE: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 98 UAE: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 99 UAE: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 100 UAE: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 101 Israel: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 102 Israel: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 103 Israel: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 104 Israel: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 105 South Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 106 South Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 107 South Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 108 South Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 113 Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 114 Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 115 Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 116 Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 117 Mexico: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 118 Mexico: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 119 Mexico: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 120 Mexico: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 121 Brazil: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 122 Brazil: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 123 Brazil: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 124 Brazil: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 125 Argentina: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 126 Argentina: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 127 Argentina: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 128 Argentina: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Global Large Molecule Drug Discovery Outsourcing Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Workflow
• Figure 7. Global Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2024 & 2034 (USD Billion)
• Figure 8. Market by Service
• Figure 9. Global Large Molecule Drug Discovery Outsourcing Market, by Service, 2024 & 2034 (USD Billion)
• Figure 10. Market by Therapeutics Area
• Figure 11. Global Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2024 & 2034 (USD Billion)
• Figure 12. Market by End Use
• Figure 13. Global Large Molecule Drug Discovery Outsourcing Market, by End Use, 2024 & 2034 (USD Billion)
• Figure 14. Global Large Molecule Drug Discovery Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
• Figure 15. Strategic Analysis - Global Large Molecule Drug Discovery Outsourcing Market

The large molecule drug discovery outsourcing market size is expected to reach USD 6.53 billion by 2034, according to a new study by Polaris Market Research. The report "Large Molecule Drug Discovery Outsourcing Market Share, Size, Trends, Industry Analysis Report By Service (Chemistry Services and Biology Services), By Workflow, By Therapeutics Area, By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Large molecule drug discovery outsourcing refers to the delegation of early-stage biologic research activities, such as target validation, HIT identification, and candidate optimization to specialized external partners to improve efficiency and innovation. The increasing focus on biologics and novel therapeutic modalities, which demand specialized capabilities not readily available in house, further contributes to the growth opportunities. Outsourcing to contract research organizations (CROs) with the right technological and scientific expertise has become a strategic necessity as biopharmaceutical companies seek to accelerate the development of complex large molecules such as monoclonal antibodies, fusion proteins, and nucleic acid-based drugs. This approach optimizes resource utilization and reduces early-stage discovery timelines while maintaining high scientific standards.

The growing integration of advanced technologies such as AI-driven drug discovery, bioinformatics, and high-throughput screening platforms into outsourcing models shapes the large molecule drug discovery outsourcing market demand. These tools improve data analysis, predictive modeling, and molecular design, encouraging CROs to offer more precise and efficient discovery processes. Companies are increasingly prioritizing technology-enabled partners who provide faster turnaround, deeper insight into biological mechanisms, and a higher chance of identifying feasible drug candidates as competition increases in the biologics space. This shift toward tech-driven outsourcing partnerships is expected to redefine the pace and quality of innovation across the large-molecule drug discovery landscape.

Large Molecule Drug Discovery Outsourcing Market Report Highlights

In terms of workflow, the lead identification and candidate optimization segment held the largest market share in 2024, owing to its critical role in refining lead compounds to ensure optimal therapeutic efficacy, safety, and drug-like properties for biologics development.

Based on service, the chemistry services segment is poised for notable expansion, fueled by its importance in enhancing the structural integrity, stability, and functionality of large-molecule drug candidates.

In 2024, North America accounted for the largest revenue share, supported by its mature biopharmaceutical industry, strong R&D investments, and a robust network of biologics-focused research organizations.

The Asia Pacific large molecule drug discovery outsourcing market is anticipated to experience rapid growth during the forecast period, driven by rising outsourcing demand, cost advantages, and the increasing establishment of specialized biologics research infrastructure.

A few global key market players include Charles River Laboratories; Dalton Pharma Services; Domainex; Eurofins Discovery; Evotec SE; GenScript; Jubilant Biosys Limited; Labcorp. (Covance); Merck & Co., Inc.; Pharmaceutical Product Development, LLC (PPD, part of Thermo Fisher); Pharmaron; QIAGEN; Syngene International Limited; TCG Lifesciences Pvt Ltd.; and WuXi AppTec.

Polaris Market Research has segmented the large molecule drug discovery outsourcing market report on the basis of workflow, service, therapeutics area, end use, and region:

By Workflow Outlook (Revenue, USD Billion, 2020-2034)

Target Identification & Screening

Target Validation & Functional Informatics

Lead Identification & Candidate Optimization

Preclinical Development

Others

By Service Outlook (Revenue, USD Billion, 2020-2034)

Chemistry Services

Biology Services

By Therapeutics Area Outlook (Revenue, USD Billion, 2020-2034)

Respiratory system

Pain and Anesthesia

Oncology

Ophthalmology

Hematology

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical & Biotechnology

Academic Institutes

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Large Molecule Drug Discovery Outsourcing Market Insights

• 4.1. Large Molecule Drug Discovery Outsourcing Market - Market Snapshot
• 4.2. Large Molecule Drug Discovery Outsourcing Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Partnerships and Platform-Based Collaboration
    • 4.2.1.2. Increasing Advancements in Drug Discovery Technology
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Supply chain disruptions and increased costs due to tariffs
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Large Molecule Drug Discovery Outsourcing Market Trends
• 4.6. Value Chain Analysis

5. Global Large Molecule Drug Discovery Outsourcing Market, by Workflow

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
• 5.3. Target Identification & Screening
  • 5.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Target Identification & Screening, by Region, 2020-2034 (USD Billion)
• 5.4. Target Validation & Functional Informatics
  • 5.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Target Validation & Functional Informatics, by Region, 2020-2034 (USD Billion)
• 5.5. Lead Identification & Candidate Optimization
  • 5.5.1. Global Large Molecule Drug Discovery Outsourcing Market, by Lead Identification & Candidate Optimization, by Region, 2020-2034 (USD Billion)
• 5.6. Preclinical Development
  • 5.6.1. Global Large Molecule Drug Discovery Outsourcing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
• 5.7. Others
  • 5.7.1. Global Large Molecule Drug Discovery Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Large Molecule Drug Discovery Outsourcing Market, by Service

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
• 6.3. Chemistry Services
  • 6.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Chemistry Services, by Region, 2020-2034 (USD Billion)
• 6.4. Biology Services
  • 6.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Biology Services, by Region, 2020-2034 (USD Billion)

7. Global Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by Respiratory system, 2020-2034 (USD Billion)
• 7.3. Respiratory system
  • 7.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Pharmaceuticals & Biotechnology, by Region, 2020-2034 (USD Billion)
• 7.4. Pain and Anesthesia
  • 7.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Pain and Anesthesia, by Region, 2020-2034 (USD Billion)
• 7.5. Oncology
  • 7.5.1. Global Large Molecule Drug Discovery Outsourcing Market, by Oncology, by Region, 2020-2034 (USD Billion)
• 7.6. Ophthalmology
  • 7.6.1. Global Large Molecule Drug Discovery Outsourcing Market, by Ophthalmology, by Region, 2020-2034 (USD Billion)
• 7.7. Hematology
  • 7.7.1. Global Large Molecule Drug Discovery Outsourcing Market, by Hematology, by Region, 2020-2034 (USD Billion)
• 7.8. Others
  • 7.8.1. Global Large Molecule Drug Discovery Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Large Molecule Drug Discovery Outsourcing Market, by End Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• 8.3. Pharmaceuticals & Biotechnology
  • 8.3.1. Global Large Molecule Drug Discovery Outsourcing Market, by Pharmaceuticals & Biotechnology, by Region, 2020-2034 (USD Billion)
• 8.4. Academic Institutes
  • 8.4.1. Global Large Molecule Drug Discovery Outsourcing Market, by Academic Institutes, by Region, 2020-2034 (USD Billion)

9. Global Large Molecule Drug Discovery Outsourcing Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Large Molecule Drug Discovery Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Large Molecule Drug Discovery Outsourcing Market - North America
  • 9.3.1. North America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • 9.3.2. North America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • 9.3.3. North America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • 9.3.4. North America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.3.5. Large Molecule Drug Discovery Outsourcing Market - US
    • 9.3.5.1. US: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.3.5.2. US: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.3.5.3. US: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.3.5.4. US: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.3.6. Large Molecule Drug Discovery Outsourcing Market - Canada
    • 9.3.6.1. Canada: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• 9.4. Large Molecule Drug Discovery Outsourcing Market - Europe
  • 9.4.1. Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.5. Large Molecule Drug Discovery Outsourcing Market - UK
    • 9.4.5.1. UK: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.6. Large Molecule Drug Discovery Outsourcing Market - France
    • 9.4.6.1. France: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.7. Large Molecule Drug Discovery Outsourcing Market - Germany
    • 9.4.7.1. Germany: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.8. Large Molecule Drug Discovery Outsourcing Market - Italy
    • 9.4.8.1. Italy: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.9. Large Molecule Drug Discovery Outsourcing Market - Spain
    • 9.4.9.1. Spain: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.10. Large Molecule Drug Discovery Outsourcing Market - Netherlands
    • 9.4.10.1. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.11. Large Molecule Drug Discovery Outsourcing Market - Russia
    • 9.4.11.1. Russia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.12. Large Molecule Drug Discovery Outsourcing Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• 9.5. Large Molecule Drug Discovery Outsourcing Market - Asia Pacific
  • 9.5.1. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.5. Large Molecule Drug Discovery Outsourcing Market - China
    • 9.5.5.1. China: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.6. Large Molecule Drug Discovery Outsourcing Market - India
    • 9.5.6.1. India: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.7. Large Molecule Drug Discovery Outsourcing Market - Malaysia
    • 9.5.7.1. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.8. Large Molecule Drug Discovery Outsourcing Market - Japan
    • 9.5.8.1. Japan: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.9. Large Molecule Drug Discovery Outsourcing Market - Indonesia
    • 9.5.9.1. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.10. Large Molecule Drug Discovery Outsourcing Market - South Korea
    • 9.5.10.1. South Korea: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.11. Large Molecule Drug Discovery Outsourcing Market - Australia
    • 9.5.11.1. Australia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.12. Large Molecule Drug Discovery Outsourcing Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• 9.6. Large Molecule Drug Discovery Outsourcing Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.5. Large Molecule Drug Discovery Outsourcing Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.6. Large Molecule Drug Discovery Outsourcing Market - UAE
    • 9.6.6.1. UAE: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.7. Large Molecule Drug Discovery Outsourcing Market - Israel
    • 9.6.7.1. Israel: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.8. Large Molecule Drug Discovery Outsourcing Market - South Africa
    • 9.6.8.1. South Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.9. Large Molecule Drug Discovery Outsourcing Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
• 9.7. Large Molecule Drug Discovery Outsourcing Market - Latin America
  • 9.7.1. Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.5. Large Molecule Drug Discovery Outsourcing Market - Mexico
    • 9.7.5.1. Mexico: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.6. Large Molecule Drug Discovery Outsourcing Market - Brazil
    • 9.7.6.1. Brazil: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.7. Large Molecule Drug Discovery Outsourcing Market - Argentina
    • 9.7.7.1. Argentina: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.8. Large Molecule Drug Discovery Outsourcing Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Large Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Charles River Laboratories
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Dalton Pharma Services
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Domainex
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Eurofins Discovery
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Evotec SE
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. GenScript
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Jubilant Biosys Limited
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Labcorp. (Covance)
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Labcorp. (Covance)
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Pharmaceutical Product Development, LLC (PPD, part of Thermo Fisher)
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Pharmaron
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. QIAGEN
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. Syngene International Limited
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. TCG Lifesciences Pvt Ltd.
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development
• 11.15. WuXi AppTec
  • 11.15.1. Company Overview
  • 11.15.2. Financial Performance
  • 11.15.3. Product Benchmarking
  • 11.15.4. Recent Development